NCT06851546Completed
Efficacy of Selective Laser Trabeculoplasty Targeting Nasal Versus Inferior 180-degree
Source: ClinicalTrials.gov · Last updated 7 Jan 2026
Brief summary (registry, in English)
The purpose of this study to optimize Selective Laser Trabeculoplasty (SLT) application when used in the management of open angle glaucoma (OAG)
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 13 (actual)
- First submitted
- 24 Feb 2025
- Start date
- 6 Jan 2025
- Primary completion date
- 10 Nov 2025
- Lead sponsor
- Mayo Clinic
- Diseases
- Glaucoma
- NCT number
- NCT06851546
What you commit to
- Study type: Interventional
- Participants enrolled: 13
- From 6 Jan 2025 to the primary completion date, 10 Nov 2025
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous history of either laser treatment or intraocular surgery, except for non-complicated cataract surgery (performed \>6 months before SLT)
- Current use of steroids (ocular, periocular, or systemic)
Other illness
- History of ocular trauma
Other
- Unwilling or unable to give consent
- Unable to attend scheduled post-operative visits
- Narrow angles
- Retinal detachment
- Active iris neovascularization or active proliferative retinopathy
- Active uveitis
- Monocular patients
Who the study is looking for
- Age 18 years and older
- Ability to comprehend the study procedures and agreement to proceed with primary SLT treatment
- Diagnosis of primary or secondary open angle glaucoma or glaucoma suspects with ocular hypertension
- Bilateral disease
- Pre-SLT IOP \>21 mmHg measured at least twice during patient's lifetime with or without medication
- Open angles with moderate to intense trabecular pigmentation
- Mild to moderate visual field defects (24-2 standard mean deviations better than the Swedish interactive thresholding algorithm standard of 12 dB)
- No adequate IOP control (low treatment compliance, substantial adverse effects with eyedrops, and at least 2 IOP measurements higher than the individualized target IOP)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Eye Care Centre, Victoria General Hospital Coordinator of this site? Confirm its status | Halifax | Canada | Unknown status |
| Mayo Clinic in Rochester Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.